Nuvation Bio NUVB
NYSE NUVB
$4.86 +0.09 (+1.89%)
As of: Oct 21, 2026 · 3:59 PM EDT

Nuvation Bio (NUVB) Asset Utilization Ratio (2024 - 2026)

Updated

Nuvation Bio's (NUVB) Asset Utilization Ratio was 0.25 for Q2 2026, up 895.7% from 0.03 a year earlier and up 5.7% from the prior quarter.

Analysis

Nuvation Bio (NUVB) Asset Utilization Ratio (2024 - 2026) Analysis & Trends

For FY2025, Asset Utilization Ratio at Nuvation Bio was 0.11, up 717.7% from FY2024.

  • By year, Asset Utilization Ratio came in at 0.01 in FY2024.
  • The Q2 2026 figure ranks as the highest quarterly Asset Utilization Ratio in data going back to Q2 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 0.24 (Q1 2026), 0.11 (Q4 2025) and 0.04 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.62
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.49
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.47
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.52
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.46
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.51
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.40
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.58
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Nuvation Bio 1.70 Bn -576.18 Mn - 0.25
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.25
Mar 31, 2026 0.24
Dec 31, 2025 0.11
Sep 30, 2025 0.04
Jun 30, 2025 0.03
Mar 31, 2025 0.02
Dec 31, 2024 0.01
Sep 30, 2024 0.00
Jun 30, 2024 0.00
API Access

Nuvation Bio Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=NUVB&period=max&api_key=YOUR_API_KEY